Medpace Holdings: Great Quarter, Stale Backlog, Full Valuation (NASDAQ:MEDP)

Core Viewpoint - Medpace Holdings, Inc. (MEDP) is rated a Buy based on the analysis conducted on April 4, 2025, indicating a positive outlook for the stock [1]. Company Analysis - The analyst has a beneficial long position in MEDP shares, indicating confidence in the company's future performance [1]. - The focus of the analysis is on identifying strong businesses at reasonable prices, suggesting that Medpace is perceived as a solid investment opportunity [1]. Investment Strategy - The investment approach includes a mix of long-term holding and trend-following strategies, reflecting a comprehensive investment philosophy [1]. - There is a slight bias towards technology companies, but the analysis maintains a broad perspective, including opportunities in other sectors such as crypto [1].